Becton, Dickinson and Company (BDX) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Becton, Dickinson and Company (BDX:NYSE), powered by AI.

Current Price
$146.24
P/E Ratio
25.1
Market Cap
42.1B
Sector
Healthcare
What is the Becton, Dickinson and Company stock price forecast?

Becton, Dickinson and Company is currently trading at $146.24. View real-time AI analysis on Alpha Lenz.

What is Becton, Dickinson and Company insider trading activity?

View the latest insider trading data for Becton, Dickinson and Company on Alpha Lenz.

What is Becton, Dickinson and Company's P/E ratio?

Becton, Dickinson and Company's P/E ratio is 25.1.

Becton, Dickinson and Company

NYSE · BDX
$146.24-1.11(-0.75%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Becton, Dickinson and Company's future dividend policy...
Alpha Chat Insight

Becton, Dickinson and Company trades at a P/E of 25.1 (premium valuation) with modest ROE of 6.5%.

Ask for details

Company Overview

Becton, Dickinson and Company, commonly known as BD, is a prominent American multinational corporation engaged in the development and manufacture of a diverse range of medical devices, instrument systems, and reagents. A key player in the healthcare industry, BD focuses on improving medical discovery, diagnostics, and the delivery of care. BD's products are instrumental in supporting healthcare professionals worldwide in enhancing patient safety and reducing the risks associated with healthcare workers. The company operates across three main segments: BD Medical, BD Life Sciences, and BD Interventional, impacting various sectors such as pharmaceuticals, hospital healthcare systems, and clinical laboratories. With a strong commitment to innovation and quality, Becton, Dickinson and Company contributes significantly to advancements in patient care, operating efficiency in medical settings, and is noted for its commitment to addressing healthcare challenges on a global scale. Headquartered in Franklin Lakes, New Jersey, BD maintains a robust presence across numerous countries, underpinning its influential role in the evolution and improvement of global healthcare infrastructure.

CEOMr. Thomas E. Polen Jr.
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees70,000

Company Statistics

FY 2025

Profile

$42.07BMarket Cap
$21.84BRevenue
0.00Shares Out
70,000Employees

Margins

45.44%Gross
24.80%EBITDA
13.67%Operating
8.61%Pre-Tax
7.68%Net

Valuation

25.07P/E
1.66P/B
1.93EV/Sales
11.19EV/EBITDA
15.75P/FCF

Growth (CAGR)

4.99%Rev 3Yr
6.32%Rev 5Yr
6.46%Op Inc 3Yr
19.78%Op Inc 5Yr
-1.93%Net Inc 3Yr
13.93%Net Inc 5Yr

Returns

2.98%ROA
6.54%ROE
4.43%ROIC

Financial Health

$641.00MCash & Cash Equivalents
$29.29BNet Debt
117.90%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Becton, Dickinson and Company (ticker: BDX) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 70,000 employees. Market cap is $42.1B.

The current price is $146.24 with a P/E ratio of 25.07x and P/B of 1.66x.

ROE is 6.54% and operating margin is 13.67%. Annual revenue is $21.8B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Becton, Dickinson and Company (BDX) Stock Forecast 2026 $146.24 — Price, Financials & Analyst Targets | Alpha Lenz